Diseases, Conditions, Syndromes

Ebola vaccine promising in first human trials

Researchers say they're a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

HIV & AIDS

Individual genotype influences effectiveness of HIV vaccine

Almost 40 million people worldwide live with HIV/AIDS. Despite great effort, HIV-1 vaccine development has been challenging. A recent HIV vaccine trial, known as RV144, revealed that a combination of 2 vaccines protected ...

Diseases, Conditions, Syndromes

US-based scientist makes potent version of H1N1 flu

A US-based Japanese scientist said Wednesday he has succeeded in engineering a version of the so-called swine flu virus that would be able to evade the human immune system.

Diseases, Conditions, Syndromes

Malaria severity not determined solely by parasite levels in blood

Although malaria kills some 600,000 African children each year, most cases of the mosquito-borne parasitic disease in children are mild. Repeated infection does generate some immunity, and episodes of severe malaria are unusual ...

Immunology

Thousands of unknown antigens identified

Researchers of Utrecht University, Intravacc and the National Institute of Public Health and Environmental Protection used a new method to identify hitherto unknown peptide antigens. This type of antigen had long been searched ...

Medications

Intranasal vaccine protects mice against West Nile infection

Researchers from Duke University have developed a nasal vaccine formulation that provides protective immunity against West Nile virus (WNV) infection in mice after only 2 doses. They present their findings at the 2014 American ...

page 6 from 10